Vosaroxin (voreloxin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vosaroxin (voreloxin), covering 2018-12-28 to 2018-12-28. Get the full timeline:
Most recent: Clinical Trial Update: Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy [Phase 1, Phase 2]